Sign In
Buy CUBT
$1.45
+0.250 (+20.83%)
At Close: Jul 10, 2026
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement
07:00am, Thursday, 07'th May 2026
PennVet Study to Evaluate GMP-Grade Metformin Eye Drops in a Canine Model Supporting Human and Veterinary Development Pathways Palm Beach Gardens, FL, May 07, 2026 (GLOBE NEWSWIRE) -- Curative Biotech
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
07:05pm, Monday, 23'rd Mar 2026
Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBTD) (“Curative” or the
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
07:00am, Monday, 23'rd Mar 2026
Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the "Comp
Curative Biotechnology Announces Canadian Patent Allowance
08:45am, Friday, 23'rd Jan 2026
“Druggable Target to Treat Retinal Degeneration” Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the “Company”), a company
Curative Biotechnology, Inc. Announces Letter to Shareholders
08:15am, Tuesday, 18'th Nov 2025
Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a devel
Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor
09:45am, Friday, 13'th Dec 2024
Palm Beach Gardens, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel
Curative Biotechnology, Inc. Announces Nomination of Dr.
07:20pm, Sunday, 31'st Mar 2024
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical comp
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
07:00pm, Sunday, 31'st Mar 2024
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical compa
Curative Biotechnology, Inc. Announces Nomination of Dr.
10:50pm, Friday, 22'nd Mar 2024
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on nov
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
09:45am, Friday, 22'nd Mar 2024
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on nove
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
09:45am, Monday, 08'th Jan 2024
Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
09:45am, Tuesday, 31'st Oct 2023
Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
01:45pm, Tuesday, 03'rd May 2022 InvestorsHub
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA)
Boca Raton, FL -- May 3, 2022 -- InvestorsHub NewsWire -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative Biotech" or the "Company"), a development-s...
CURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO
10:12am, Tuesday, 12'th Oct 2021
Dr. Sohn to Oversee Development of Next Gen COVID-19 Vaccine to Treat Kidney Failure Patients , Late-Stage Rabies Therapeutic and Age-related Macular Degeneration
CURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE
10:20am, Thursday, 07'th Oct 2021
License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies
